ET/CT-18F-fluorodeoxyglucose in POEMS syndrome. Clinical Case
https://doi.org/10.37174/2587-7593-2024-7-3-96-100
Abstract
A brief review of the literature and our own detailed description of POEMS syndrome according to PET/CT data with 18F FDG in a 26-year-old patient are provided. A comprehensive examination was carried out and appropriate systemic therapy was prescribed.
About the Authors
B. M. KhakulovaRussian Federation
Bella M. Khakulova
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
A. S. Subbotin
Russian Federation
Aleksey S. Subbotin
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
A. I. Pronin
Russian Federation
Artem I. Pronin
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
A. A. Semenova
Russian Federation
Anastasia A. Semenov
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
References
1. Multiple myeloma and plasma cell diseases. A short reference/ K. Ramasamy, S. Lonial; 2018 (In Russ.).
2. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712-20
3. Scheinker I. Myelom und Nervensystem: Über eine bisher nicht beschriebene mit eigentumlichen Hautveranderungen einhergehende Polyneuritis bei einem plasmazellularen Mye lom des Sternums. Deutsche Zeitschriſt fur Nerven- heilkunde. 1938;147:247-73 (In Germ.).
4. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome: report on two cases and a review of the literature. Medicine. 1980;59:311-22.
5. Takatsuki K, Yodoi J, Wikasaka K, et al. Plasma cell dyscrasia with polyneuritis and an endocrine anomaly: endocrinological study of a new syndrome. Nippon Rinsho. 1974;50:2444-56.
6. Crow RS. Peripheral neuritis in myelomatosis. Br Med J. 1956;2:802-4.
7. Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflam matory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012;83:476-9.
8. Klodzinskiy AA, Ryzhko VV, Sorkina OM, et al. POEMS syndrome (a case report and literature review). Clinical Oncohematology. 2008;1(2):145-55. (In Russ.).
9. Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999;34:633-8.
10. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve. 2000;23:1051-6.
11. Dispenzieri A, Lacy MQ, Hayman SR, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraſtment syndrome. Eur J Haematol. 2008;80:397-406.
12. Dispenzieri A. POEMS Syndrome: 2019 Update on diag nosis, risk-stratification, and management. Am J Hematol. 2019;94(7):812-27. https://doi.org/10.1002/ajh.25495. PMID: 31012139.
13. Pan Q, Li J, Li F, et al. Characterizing POEMS Syndrome with 18F-FDG PET/CT. J Nucl Med. 2015 Sep;56(9):1334-7. https://doi.org/10.2967/jnumed.115.160507. PMID: 26182964.
14. Albertí MA, Martinez-Yélamos S, Fernandez A, et al. 18F FDG PET/CT in the evaluation of POEMS syndrome. Eur J Radiol. 2010 Nov;76(2):180-2. PMID: 19581061. https://doi.org/10.1016/j.ejrad.2009.06.004.
Review
For citations:
Khakulova B.M., Subbotin A.S., Pronin A.I., Semenova A.A. ET/CT-18F-fluorodeoxyglucose in POEMS syndrome. Clinical Case. Journal of oncology: diagnostic radiology and radiotherapy. 2024;7(3):96-100. (In Russ.) https://doi.org/10.37174/2587-7593-2024-7-3-96-100